4//SEC Filing
Stilley William B. III 4
Accession 0001213900-22-050596
CIK 0001513525other
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 7:14 PM ET
Size
5.6 KB
Accession
0001213900-22-050596
Insider Transaction Report
Form 4
Stilley William B. III
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock Options
2022-08-22+100,000→ 100,000 totalExercise: $0.56From: 2022-09-01Exp: 2032-08-21→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Stock options to purchase 100,000 shares of the Company's common stock, vesting 50% after Purnovate, Inc. has held a pre-IND meeting with the FDA and the balance when the IND is granted.
Documents
Issuer
ADIAL PHARMACEUTICALS, INC.
CIK 0001513525
Entity typeother
Related Parties
1- filerCIK 0001718069
Filing Metadata
- Form type
- 4
- Filed
- Aug 22, 8:00 PM ET
- Accepted
- Aug 23, 7:14 PM ET
- Size
- 5.6 KB